Adiponectin is known to decrease hepatic insulin resistance and to attenuate liver inflammation and fibrosis through binding to AdipoR1 and AdipoR2, the latter is preferentially expressed in rodents livers [39,40]. The gene discussed is ADIPOQ; the disease is Insulin resistance.